Unfortunately, previous cytogenetic studies are restricted to investigating allelic imbalance of the TP53, MDM2, and CDKN2A loci in ESFT patient material, hence the frequency of MDM4 amplifications in Ewing Sarcoma is currently unknown. Here, CDKN2A is linked to Ewing sarcoma.